Anhiba



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 36.9%
Ill-defined Disorder 17.8%
Drug Use For Unknown Indication 14.0%
Pyrexia 6.9%
Upper Respiratory Tract Inflammation 6.9%
Infection 4.1%
Constipation 2.7%
Oral Herpes 2.2%
Asthma 1.7%
Hyperthermia 1.3%
Pancytopenia 0.9%
Pharyngitis 0.9%
Dehydration 0.6%
Diuretic Therapy 0.6%
Sinusitis 0.6%
Abdominal Pain Upper 0.3%
Analgesia 0.3%
Hyperlipidaemia 0.3%
Infection Prophylaxis 0.3%
Myocardial Ischaemia 0.3%
Pyrexia 24.5%
Toxic Epidermal Necrolysis 17.0%
Drug Rash With Eosinophilia And Systemic Symptoms 15.1%
Drug Reaction With Eosinophilia And Systemic Symptoms 11.3%
Completed Suicide 3.8%
Convulsion 3.8%
Erythema Multiforme 3.8%
Intentional Overdose 3.8%
Lymphocyte Stimulation Test Positive 3.8%
Transplant Failure 3.8%
Vomiting 3.8%
Intentional Drug Misuse 1.9%
Renal Impairment 1.9%
Stevens-johnson Syndrome 1.9%
Concomitant
Product Used For Unknown Indication 12.4%
Sedation 9.4%
Fluid Replacement 9.0%
Infection 7.9%
Influenza 6.9%
Autism Spectrum Disorder 6.0%
Irritability 6.0%
Prophylaxis 5.9%
Drug Use For Unknown Indication 5.2%
Pyrexia 5.2%
Ureteral Stent Insertion 4.2%
Ureteral Stent Removal 4.2%
Diuretic Therapy 3.3%
Electrolyte Substitution Therapy 2.5%
Insomnia 2.2%
Pain 2.2%
Infection Prophylaxis 2.0%
Meningitis 2.0%
Bronchitis 1.8%
Fungal Infection 1.8%
Abnormal Behaviour 13.9%
Hallucination 13.9%
Sepsis 11.4%
Peripheral Vascular Disorder 5.1%
Pneumonia 5.1%
Respiratory Failure 5.1%
Vomiting 5.1%
Aggression 3.8%
Hallucination, Auditory 3.8%
Renal Impairment 3.8%
Sudden Death 3.8%
Systemic Candida 3.8%
Ventricular Tachycardia 3.8%
Convulsion 2.5%
Disseminated Intravascular Coagulation 2.5%
Dizziness 2.5%
Drug Rash With Eosinophilia And Systemic Symptoms 2.5%
Encephalitis Herpes 2.5%
Erythema Multiforme 2.5%
Fear 2.5%